About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Multiple Sclerosis Patients Helped With Asthma Medication

by Rathi Manohar on September 14, 2010 at 10:01 PM
Font : A-A+

 Multiple Sclerosis Patients Helped With Asthma Medication

Patients with multiple sclerosis could be helped by Albuterol, a drug used to treat asthma and other respiratory diseases, states a new research study.

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the degeneration of myelin, which coats nerve cells in the white matter of the central nervous system.

Advertisement

Patients with the condition have been found to have elevated levels of interleukin-12, a biological compound that promotes the generation of a type of helper T cell that may be associated with myelin destruction.

Albuterol sulfate-commonly used to treat bronchospasm, a constriction of the airways within the lungs as often occurs in asthma-may decrease interleukin-12 levels, the authors note.
Advertisement

Samia J. Khoury, of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues assessed the effects of albuterol treatment as an add-on therapy for patients starting treatment with glatiramer acetate, currently approved as a therapy for relapsing-remitting MS.

A total of 44 patients were randomly assigned to receive daily subcutaneous (underneath the skin) 20-milligram injections of glatiramer acetate plus either an oral dose of 4 milligrams of albuterol or placebo daily for two years.

Participants were examined by a neurologist at the beginning of the study and at six, 12, 18 and 24 months, and blood samples were collected at the beginning and three, six and 12 months into the study.

Magnetic resonance imaging (MRI) of the brain was performed at enrollment, 12 months and 24 months.

A total of 39 patients participated long enough to contribute to the analysis.

In assessments of functional status, improvement was observed in the glatiramer acetate plus albuterol group compared with the placebo group at six months and 12 months but not at 24 months.

Compared to patients taking placebo, those taking albuterol also experienced a delay in the time to their first relapse.

"We conclude that treatment with glatiramer acetate plus albuterol is well tolerated and improves clinical outcomes in patients with multiple sclerosis. The combined regimen seems to enhance clinical response during the first year of therapy," the authors said.

The study appears in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
World Heart Day in 2022- Use Heart for Every Heart
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Childhood Asthma Asthma Chemotherapy Chemotherapy Drugs Infectious Mononucleosis Multiple Sclerosis Treatment and Modify Remedies for Seasonal Allergy Relief Optic Neuritis Autoimmune Disorders Allergy - Symptom Evaluation 

Most Popular on Medindia

Post-Nasal Drip Selfie Addiction Calculator Find a Hospital Nutam (400mg) (Piracetam) How to Reduce School Bag Weight - Simple Tips Indian Medical Journals Blood Pressure Calculator Daily Calorie Requirements Vent Forte (Theophylline) Hearing Loss Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Multiple Sclerosis Patients Helped With Asthma Medication Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests